ReviewInfectious diseases and therapy2016

Atazanavir and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Patients: A Systematic Review.

Dominic Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.